The chemokine receptor variant CCR5delta32 is linked to HIV-1 infection resistance and other pathological conditions. In European populations, the allele frequency ranges from 10-16%, and its evolution has been extensively debated throughout the years. We provide a detailed perspective of the evolutionary history of the deletion through time and space. We discovered that the CCR5delta32 allele arose on a pre-existing haplotype consisting of 84 variants. Using this information, we developed a haplotype-aware probabilistic model to screen for this deletion across 860 low-coverage ancient genomes and we found evidence that CCR5delta32 is at least 7,000 years BP in age, with a likely origin somewhere in the Western Eurasian Steppe region. We further show evidence that the CCR5delta32 haplotype underwent positive selection between 7,000-2,000 BP in Western Eurasia and that the presence of the haplotype in Latin America can be explained by post-Columbian genetic exchanges. Finally, we point to new complex CCR5delta32 genotype-haplotype-phenotype relationships, which demand consideration when targeting the CCR5 receptor for therapeutic strategies.
Tracing the evolutionary path of the CCR5delta32 deletion via ancient and modern genomes
K. Ravn,L. Cobuccio,R. Muktupavela,J. Meisner,M. Benros,T. Korneliussen,M. Sikora,E. Willerslev,M. Allentoft,E. K. Irving-Pease,F. Racimo,S. Rasmussen
Published 2023 in medRxiv
ABSTRACT
PUBLICATION RECORD
- Publication year
2023
- Venue
medRxiv
- Publication date
2023-06-20
- Fields of study
Biology, Medicine
- Identifiers
- External record
- Source metadata
Semantic Scholar
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-78 of 78 references · Page 1 of 1
CITED BY
Showing 1-1 of 1 citing papers · Page 1 of 1